Strong emu Clinical Trial & Program Progress
Filed with ASX · · 5 pages · English
Summary by 6ix AI
EMvision Medical Devices Ltd. provides an update on the progress of its emu clinical trial and related programs. The company reports that seven hospitals are actively recruiting patients for the pivotal trial, with additional sites being activated to enhance recruitment. The continuous innovation study is also progressing, providing valuable data for algorithm enhancement and device development. A grant-funded regional benefits study is set to launch, aimed at demonstrating the emu brain scanner's effectiveness in regional areas.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EMvision Medical Devices Ltd. on 6ix
Story so far
Earlier from EMvision Medical Devices
- First Responder Aeromedical Study Commences
- Oversubscribed SPP Raises $2.0M
- Oversubscribed SPP To Close Early
- $3m CRC-P Grant Executed & First Payment Received
- SPP Offer Document & Option Prospectus
Later from EMvision Medical Devices
- Quarterly Activities/Appendix 4C Cash Flow Report
- Half Yearly Report and Accounts
- EMVision Medical Devices to Present at Australia Investor Day February 26th
- S&P DJI Announces March 2026 Quarterly Rebalance
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices